Dash BioBiotech
Dash Bio builds bioinformatics software for researchers and biotech companies to analyze and visualize genomic data.
$30MSeries A
Investor undisclosed
A $30M Series A for genomics visualization software signals that biotech tooling—especially the unglamorous but essential layer between raw data and insights—is finally getting serious capital. At this stage and size, Dash Bio is likely hiring hard on product/eng and building out enterprise sales motion, which means the market for "boring" infrastructure is maturing past the DIY phase. If you're building any kind of data platform for life sciences, this validates that customers will pay for tools that save researchers weeks of work, even if it's not a direct therapeutic.